Regional and national burden and aetiologies of non-COVID lower respiratory infections in Latin America and the Caribbean, 1990–2023: a secondary analysis of the global burden of disease study 2023

Background Lower respiratory tract infections (LRTIs) remain a leading cause of morbidity and mortality worldwide, disproportionately affecting low- and middle-income regions. Reliable, up-to-date burden estimates are needed to inform public health strategies in Latin America and the Caribbean, where prevention and management strategies remain heterogeneous. We aimed to characterise temporal and geographical patterns in LRTI mortality, incidence, disability-adjusted life-years (DALYs), and aetiology across the region from 1990 to 2023. Methods We analysed secondary, modelled estimates of mortality, incidence, and DALYs attributable to LRTIs in Latin America and the Caribbean from 1990 to 2023, extracted from the GBD 2023 Results Tool and produced following the standardised GBD protocol coordinated by the Institute for Health Metrics and Evaluation (IHME). Findings In Latin America and the Caribbean, LRTI mortality declined in most countries between 1990 and 2023, with the steepest reductions among children younger than five years (e.g., Brazil ARC −6·16, 95% UI −6·61 to −5·71). All-age mortality rose in some countries, but age-standardised rates showed that these increases reflected population ageing rather than rising age-specific risk. Following a sustained pre-pandemic decline, incidence showed and overall upward direction in the post-pandemic period across age groups, although the magnitude and statistical relevance of these changes varied by age and country, with the largest increase observed among children in Suriname (ARC +8·84, 95% UI +2·80 to +14·95). Streptococcus pneumoniae remained the leading cause of LRTI mortality in 2023 (7·68 per 100,000, 95% UI 7·11–8·24; ARC −2·70, 95% UI −2·96 to −2·45). Interpretation LRTIs remain a major cause of death in the region, with substantial progress among children but persistent burden among older adults, driven by population ageing, and evidence of a post-pandemic increase in incidence. There is a great importance of combining clinical interventions with broader public health strategies addressing vaccination coverage, antimicrobial-resistance surveillance, nutrition, housing, and access to primary care, particularly in populations that have experienced less favourable trends. Funding Wellcome Trust (303666/Z/23/Z); UK International Development (301542–403); the Gates Foundation (INV–063472) and Universidad de La Sabana (MED–289–2020).

Authors

Institutions

Publication Details

Journal
The Lancet Regional Health - Americas
Published
2026-11-13
DOI
https://doi.org/10.1016/j.lana.2026.101686
Primary Topic
Pneumonia and Respiratory Infections
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Regional and national burden and aetiologies of non-COVID lower respiratory infections in Latin America and the Caribbean, 1990–2023: a secondary analysis of the global burden of disease study 2023

Vincent Mougin, Cristian C. Serrano-Mayorga, Eve E Wool, Natalia Sanabria-Herrera et al.
1 links
The Lancet Regional Health - Americas
Pneumonia and Respiratory Infections
article

Regional and national burden and aetiologies of non-COVID lower respiratory infections in Latin America and the Caribbean, 1990–2023: a secondary analysis of the global burden of disease study 2023

Vincent Mougin, Cristian C. Serrano-Mayorga, Eve E Wool, Natalia Sanabria-Herrera, Luis Felipe Reyes, Juan Sebastián Hurtado, Valeria Aguirre-Gutierrez, Luis Fernanda Martinez, Mohsen Naghavi, Daniel C. Tellez-Barros
article en

Abstract

Background Lower respiratory tract infections (LRTIs) remain a leading cause of morbidity and mortality worldwide, disproportionately affecting low- and middle-income regions. Reliable, up-to-date burden estimates are needed to inform public health strategies in Latin America and the Caribbean, where prevention and management strategies remain heterogeneous. We aimed to characterise temporal and geographical patterns in LRTI mortality, incidence, disability-adjusted life-years (DALYs), and aetiology across the region from 1990 to 2023. Methods We analysed secondary, modelled estimates of mortality, incidence, and DALYs attributable to LRTIs in Latin America and the Caribbean from 1990 to 2023, extracted from the GBD 2023 Results Tool and produced following the standardised GBD protocol coordinated by the Institute for Health Metrics and Evaluation (IHME). Findings In Latin America and the Caribbean, LRTI mortality declined in most countries between 1990 and 2023, with the steepest reductions among children younger than five years (e.g., Brazil ARC −6·16, 95% UI −6·61 to −5·71). All-age mortality rose in some countries, but age-standardised rates showed that these increases reflected population ageing rather than rising age-specific risk. Following a sustained pre-pandemic decline, incidence showed and overall upward direction in the post-pandemic period across age groups, although the magnitude and statistical relevance of these changes varied by age and country, with the largest increase observed among children in Suriname (ARC +8·84, 95% UI +2·80 to +14·95). Streptococcus pneumoniae remained the leading cause of LRTI mortality in 2023 (7·68 per 100,000, 95% UI 7·11–8·24; ARC −2·70, 95% UI −2·96 to −2·45). Interpretation LRTIs remain a major cause of death in the region, with substantial progress among children but persistent burden among older adults, driven by population ageing, and evidence of a post-pandemic increase in incidence. There is a great importance of combining clinical interventions with broader public health strategies addressing vaccination coverage, antimicrobial-resistance surveillance, nutrition, housing, and access to primary care, particularly in populations that have experienced less favourable trends. Funding Wellcome Trust (303666/Z/23/Z); UK International Development (301542–403); the Gates Foundation (INV–063472) and Universidad de La Sabana (MED–289–2020).

The Lancet Regional Health - AmericasVol. 66
Universidad de La Sabana (CO), Institute for Health Metrics and Evaluation (US), University of Oxford (GB), International Severe Acute Respiratory and Emerging Infection Consortium (GB)
Bill and Melinda Gates Foundation, Wellcome Trust, Department for International Development, Universidad de La Sabana
Good health and well-being, Reduced inequalities
Pneumonia and Respiratory Infections
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon